"With government and industry working hand in hand, we can develop and stockpile monoclonal antibody therapeutics in anticipation of variants to come. We need to be thinking several moves ahead to keep ahead of variants so that stockpiles of therapies do not become obsolete as they have now. Our government needs to ensure the proper funding to support the development and manufacturing of such therapies, and we need to begin demanding they do so.

These are highly complex and time and resource-intensive endeavors. However, the technology exists today through modern antibody platforms to address these needs, and countless lives can be saved with such an approach. The more action we take now, the more we can be ready for future variants from threatening our nation's health."

Ian Chan is a health care executive.

He shares his story and discusses his KevinMD article, "To treat future COVID variants, we need more than vaccines."

Did you enjoy today's episode?

Rate and review the show so more audiences can find The Podcast by KevinMD.

Subscribe on your favorite podcast app to get notified when a new episode comes out.

Reflect and earn 1.0 AMA PRA Category 1 CME for this episode.

Also available in Category 1 CME bundles.

Powered by CMEfy - a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info